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         Editorial 
 
 
 
 
Stem cell research meets aging research. Recent findings 
indicate  that  cell  reprogramming  share  some  regulatory 
mechanisms  with  aging.  Modulation  of  epigenetic 
enzymes, blockage of TGF-β, MEK, and GSK3b cascades, 
as  well  as  avoidance  of  oxidation  can  enhance  the 
generation  of  iPSCs  [1,  2].  Interestingly,  dysfunction  of 
these pathways has been considered as a cause of aging 
[3].  Our  latest  study  adds  one  more  evidence  that 
inhibition  of  IGF/PI-3K/mTOR  pathway,  activation  of 
sirtuin, induction of autophagy,  which all associate  with 
increased longevity and the delayed onset of age-related 
disorders [4, 5], promote somatic cell reprogramming [6]. 
 
These parallels could not be merely coincident. Organism 
aging involves decline of self-renew compartment function 
and  somatic  stem  cell  replication,  which  might  be 
deteriorated by external aging-cues or aged stem cell niche 
[7]. Telomere dysfunction and/or DNA damage which are 
prevalent  in  aged  cells  correlates  with  a  decreased 
reprogramming  efficiency  [8].  Dysregulation  of  signal 
pathways  controlling  cell  proliferation  potencies  could 
decrease  efficiency  of  cell  reprogramming  [9].  The 
initiation of cell reprogramming to pluripotency involves 
coordinated epigenetic changes that alter a genome-wide 
scale of chromatin structure and gene activity which is also 
critical for cell cycle transition. Thus reprogramming and 
aging also correlate well at levels of cellular function and 
cell signaling. 
 
To date, somatic cell reprogramming has been achieved in 
vitro. It would be of great importance to explore whether 
the  anti-aging  agents,  e.g.  rapamycin,  could  function  to 
enhance stem cell function, protect stem cell prluripotency 
and even promote reprogramming in vivo. It is also very 
interesting  to  verify  whether  some  or  all  adult 
organs/tissues  do  possess  some  significant  regenerative 
capacity  due  to  the  suspected  in  vivo  reprogramming. 
Furthermore,  it  has  been  reported  that  agents  which 
effectively  function  for  a  common  human  disease  by 
enhancing  self-renewal  could  lose  efficacy  in  older 
individuals due to the age-associated decline of replication 
[10]. Thus  understanding  and  realization  of  in  vivo  cell 
reprogramming  is  not  only  a  fundamental  theoretical 
question but also a very promising strategy for anti-aging 
and regenerative medicine. 
 
Reprogramming of somatic cells has been enthusiastically 
hoped to become an arsenal to against aging as it would 
leads  to  personalized  stem-cell-based  rejuvenation 
therapies. What we learn from research of stem cell and 
reprogramming  could  help  us  to  develop  two  potential 
anti-aging  approaches  in  adult  and  older:  i)  to  protect, 
ameliorate or reverse the age-associated loss function of 
stem cell in vivo and ii) to replace the lost stem cells by 
reprogrammed  pluripotent  cells.  Considering  the  shared 
mechanisms by anti-aging and reprogramming processes, 
we speculate that applying a cocktail of pharmacological 
agents  (small  or  macro  molecules),  or  even  the  herbal 
extracts (such as the traditional Chinese medicines) might 
achieve  in  vivo  reprogramming  and  eventually  lead  to 
rejuvenation. 
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